Patterns of Prescribing and Monitoring of Palbociclib
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer|Advanced Breast Cancer|Estrogen Receptor-positive Breast Cancer|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Interventions: DRUG: Palbociclib
Sponsor: Rush University Medical Center